StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
1550
This month
7
This week
4
This year
469
Today
2
Yesterday
4
Publishing Date
2023 - 07 - 25
6
2023 - 06 - 27
6
2023 - 05 - 15
6
2023 - 05 - 09
6
2023 - 04 - 27
7
2023 - 02 - 22
5
2023 - 01 - 26
5
2023 - 01 - 09
6
2022 - 12 - 22
5
2022 - 11 - 07
5
2022 - 11 - 03
5
2022 - 08 - 08
7
2022 - 08 - 04
7
2022 - 07 - 28
5
2022 - 07 - 18
7
2022 - 06 - 28
5
2022 - 06 - 20
5
2022 - 06 - 14
5
2022 - 06 - 13
6
2022 - 06 - 07
5
2022 - 06 - 06
7
2022 - 06 - 03
5
2022 - 05 - 11
7
2022 - 04 - 26
7
2022 - 04 - 11
7
2022 - 03 - 01
8
2022 - 02 - 24
6
2022 - 02 - 22
5
2021 - 12 - 13
5
2021 - 12 - 03
5
2021 - 11 - 04
6
2021 - 10 - 18
5
2021 - 10 - 13
5
2021 - 09 - 30
6
2021 - 09 - 28
7
2021 - 09 - 09
5
2021 - 09 - 07
5
2021 - 08 - 18
5
2021 - 08 - 16
6
2021 - 08 - 09
6
2021 - 08 - 03
8
2021 - 07 - 29
6
2021 - 07 - 14
5
2021 - 07 - 09
5
2021 - 06 - 29
6
2021 - 06 - 24
5
2021 - 06 - 22
5
2021 - 06 - 21
5
2021 - 06 - 17
5
2021 - 06 - 08
5
2021 - 06 - 07
6
2021 - 06 - 03
5
2021 - 06 - 01
6
2021 - 05 - 20
5
2021 - 05 - 11
5
2021 - 05 - 04
6
2021 - 04 - 20
7
2021 - 04 - 14
6
2021 - 04 - 13
8
2021 - 04 - 07
7
Sector
Commercial services
11
Communications
6
Consumer durables
2
Consumer non-durables
14
Consumer services
2
Distribution services
5
Electronic technology
13
Energy minerals
13
Finance
21
Finance and insurance
2
Health services
27
Health technology
1550
Industrial services
1
Manufacturing
114
Miscellaneous
1
N/a
32
Process industries
11
Producer manufacturing
8
Professional, scientific, and technical services
21
Retail trade
2
Technology services
16
Transportation
1
Transportation and warehousing
1
Wholesale trade
1
Tags
Agreement
22
Alliances
38
Alzheimer's
22
Alzheimer’s
22
Antibody
47
Approval
45
Biomidwest
38
Biopharma
27
Biotech-bay
24
Biotechnology
20
Cancer
127
China
41
Chinese
25
Clinical-trials-phase-iii
30
Collaboration
66
Companies
43
Conference
69
Covid
62
Covid-19
48
Designation
21
Diabetes
56
Disease
82
Drug
93
Earnings
42
Events
30
Expected
23
Fda
67
Financial
54
Financial results
42
Global
119
Growth
85
Health
27
Heart
22
Injection
22
Insulin
37
Iot
23
License
26
Market
249
Money
32
N/a
1007
Obesity
22
People
64
Pharma
35
Pharmaceutical
21
Phase 1
24
Phase 2
34
Phase 3
47
Positive
25
Report
117
Research
129
Results
190
Risk
24
Sabizabulin
22
Study
58
Technology
25
Therapeutics
116
Therapy
79
Treatment
166
Trial
107
Update
30
Entities
Abbott laboratories
51
Abbvie inc.
94
Abcellera biologics inc
12
Ac immune sa
34
Adc therapeutics sa
13
Agios pharmaceuticals, inc.
10
Akouos, inc.
10
Alexion pharmaceuticals, inc.
43
Alnylam pharmaceuticals, inc.
37
Amgen inc.
75
Astellas pharma inc
19
Astrazeneca plc
83
Aveo pharmaceuticals, inc.
24
Baxter international inc.
13
Becton, dickinson and company
21
Beigene, ltd.
19
Biocryst pharmaceuticals, inc.
13
Biogen inc.
14
Biontech se
14
Blueprint medicines corporation
20
Bristol-myers squibb company
95
Clovis oncology, inc.
20
Dicerna pharmaceuticals, inc.
24
Eli lilly and company
1550
Epizyme, inc.
20
Exelixis, inc.
13
Gilead sciences, inc.
32
Glaxosmithkline plc
98
Icon plc
10
Illumina, inc.
15
Incyte corporation
197
Insulet corporation
13
Johnson & johnson
142
Karyopharm therapeutics inc.
20
Medtronic plc
13
Merus n.v.
20
Mylan n.v.
24
Nektar therapeutics
10
Neos therapeutics, inc.
13
Novartis ag
119
Novo nordisk a/s
77
Omeros corporation
15
Otonomy, inc.
13
Pfizer, inc.
79
Prevail therapeutics inc.
10
Proqr therapeutics n.v.
13
Regeneron pharmaceuticals, inc.
34
Rigel pharmaceuticals, inc.
41
Sanofi
291
Takeda pharmaceutical company limited
36
Terumo corp
12
Teva pharmaceutical industries limited
10
Teva pharmaceutical industries ltd
48
Thermo fisher scientific inc
11
Total se
13
United therapeutics corporation
12
Verastem, inc.
11
Veru inc.
56
Viatris inc.
18
Y-mabs therapeutics, inc.
18
Symbols
AAPL
1094
ABB
1305
ABBV
913
ABLZF
1045
ABT
1552
AMGN
698
ARVL
3808
AZN
588
BDX
723
BMY
598
BNPQF
1628
BNPQY
1628
BNPZY
1627
CNY
2021
CSCO
812
DHR
725
ERIC
1464
EXTR
581
FNCTF
6109
GE
851
GLAXF
607
GOOG
1104
GOOGL
1104
GSK
827
HON
1616
HUBS
1297
IBM
606
INR
2024
INTC
876
JNJ
3987
LLY
1550
LTUM
873
LYV
717
MDT
1196
MLPY
2022
MMM
873
MS
3647
MS-PE
1450
MSFT
1127
NOK
825
NOKBF
886
NVO
568
NVS
1111
NVSEF
904
ORCL
1082
PCRFF
591
PCRFY
591
PFE
645
PHG
886
PPRUF
1005
PPRUY
1006
SAP
1399
SAPGF
1133
SNOW
707
SNY
3999
SNYNF
3054
TMO
1431
TOT
1594
URR
2020
VZ
1059
Exchanges
Amex
5
Lse
40
Nasdaq
1005
Nyse
1550
Tsx
4
Crawled Date
2023 - 10 - 04
5
2023 - 10 - 02
5
2023 - 07 - 25
6
2023 - 07 - 17
5
2023 - 06 - 27
6
2023 - 06 - 26
5
2023 - 05 - 15
6
2023 - 05 - 09
6
2023 - 05 - 03
5
2023 - 04 - 27
5
2023 - 04 - 20
5
2023 - 02 - 28
5
2023 - 01 - 26
5
2023 - 01 - 09
6
2022 - 12 - 22
5
2022 - 11 - 07
5
2022 - 08 - 08
7
2022 - 08 - 04
7
2022 - 07 - 28
5
2022 - 07 - 18
6
2022 - 06 - 20
5
2022 - 06 - 14
5
2022 - 06 - 13
6
2022 - 06 - 07
6
2022 - 06 - 06
7
2022 - 06 - 03
5
2022 - 05 - 11
7
2022 - 04 - 26
7
2022 - 04 - 11
8
2022 - 03 - 01
8
2022 - 02 - 22
5
2021 - 12 - 13
5
2021 - 12 - 03
5
2021 - 11 - 04
5
2021 - 10 - 18
5
2021 - 10 - 13
5
2021 - 09 - 30
6
2021 - 09 - 28
7
2021 - 09 - 09
5
2021 - 09 - 07
5
2021 - 08 - 18
5
2021 - 08 - 16
6
2021 - 08 - 09
7
2021 - 08 - 03
8
2021 - 07 - 29
6
2021 - 07 - 14
5
2021 - 07 - 09
5
2021 - 06 - 29
6
2021 - 06 - 24
5
2021 - 06 - 22
6
2021 - 06 - 08
5
2021 - 06 - 07
6
2021 - 06 - 01
5
2021 - 05 - 20
5
2021 - 05 - 11
5
2021 - 05 - 04
6
2021 - 04 - 20
7
2021 - 04 - 14
6
2021 - 04 - 13
10
2021 - 04 - 07
7
Crawled Time
00:00
65
00:01
1
00:20
9
01:00
105
01:15
1
02:00
20
02:11
1
03:00
11
04:00
4
04:20
5
05:00
5
06:00
12
07:00
14
08:00
19
09:00
15
10:00
31
10:51
1
11:00
105
11:36
1
12:00
163
12:03
2
12:07
5
12:09
2
12:10
1
12:11
7
12:15
17
12:20
29
12:30
11
12:34
1
12:39
1
12:40
1
13:00
97
13:07
1
13:13
1
13:15
8
13:17
1
13:20
25
13:30
10
14:00
72
14:15
10
14:20
11
14:30
14
15:00
65
15:15
3
15:20
22
15:30
13
16:00
96
16:20
11
17:00
57
18:00
59
18:17
2
18:31
2
19:00
50
19:11
2
20:00
37
21:00
88
22:00
48
22:04
2
23:00
45
23:07
2
Source
brightmindsbio.com
1
investor.alkermes.com
2
investor.aveooncology.com
2
ir.cyclerion.com
1
ir.pulmatrix.com
1
ir.vaccinex.com
1
www.aspenpharma.com
2
www.biospace.com
543
www.brickellbio.com
2
www.chi-med.com
1
www.clarivate.com
1
www.concertpharma.com
1
www.cowen.com
1
www.emmis.com
1
www.fda.gov
36
www.firstbankonline.com
1
www.globenewswire.com
178
www.hutch-med.com
2
www.precisionbiosciences.com
2
www.preludetx.com
1
www.prnewswire.com
769
www.thermogenesis.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
Lly
save search
Innovent Announces the Phase 3 ORIENT-16 Study Results Published in JAMA Evaluating Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma
Published:
2023-12-06
(Crawled : 01:00)
- prnewswire.com
SNY
|
News
|
$46.34
-1.45%
-1.47%
1.4M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$93.9
1.45%
2.1K
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
4 d
|
$588.15
0.42%
0.09%
2M
|
Health Technology
|
Email alert
Add to watchlist
INCY
|
$54.82
-0.26%
-0.26%
1.4M
|
Health Technology
|
Email alert
Add to watchlist
rient-16
treatment
results
study
FDA Roundup: December 05, 2023
Published:
2023-12-05
(Crawled : 23:00)
- prnewswire.com
LLY
|
News
4 d
|
$588.15
0.42%
0.09%
2M
|
Health Technology
|
Email alert
Add to watchlist
fda
Vanda Pharmaceuticals Announces that U.S. Food and Drug Administration Accepts New Drug Application for Tradipitant for the Treatment of Gastroparesis
Published:
2023-12-04
(Crawled : 23:00)
- prnewswire.com
LLY
|
News
4 d
|
$588.15
0.42%
0.09%
2M
|
Health Technology
|
0.99%
|
O:
0.08%
H:
0.0%
C:
0.0%
VNDA
|
$3.96
2.86%
2.78%
610K
|
Health Technology
|
0.89%
|
O:
0.13%
H:
1.53%
C:
0.76%
drug
food
treatment
pharmaceuticals
application
Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 15, 2023
Published:
2023-12-04
(Crawled : 14:30)
- biospace.com/
LLY
|
News
4 d
|
$588.15
0.42%
0.09%
2M
|
Health Technology
|
-0.99%
|
O:
-1.96%
H:
0.0%
C:
0.0%
biopharma
acquire
Jaypirca® (pirtobrutinib) Now Approved by U.S. FDA for the Treatment of Adult Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Have Received at Least Two Lines of Therapy, Including a BTK Inhibitor and a BCL-2 Inhibitor
Published:
2023-12-01
(Crawled : 23:00)
- prnewswire.com
LLY
|
News
4 d
|
$588.15
0.42%
0.09%
2M
|
Health Technology
|
Email alert
Add to watchlist
jaypirca
fda
approved
treatment
leukemia
Verve Therapeutics Announces Closing of Public Offering of Common Stock, Full Exercise by Underwriters of Option to Purchase Additional Shares and Closing of Concurrent Private Placement
Published:
2023-12-01
(Crawled : 21:00)
- globenewswire.com
VERV
4 d
|
$11.57
-3.66%
-3.8%
1.2M
|
Professional, Scientific, and T...
|
Email alert
Add to watchlist
LLY
|
News
4 d
|
$588.15
0.42%
0.09%
2M
|
Health Technology
|
Email alert
Add to watchlist
offering
therapeutics
AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO
Published:
2023-12-01
(Crawled : 17:00)
- globenewswire.com
LLY
|
News
4 d
|
$588.15
0.42%
0.09%
2M
|
Health Technology
|
-0.49%
|
O:
0.5%
H:
0.0%
C:
0.0%
ACIU
|
$3.435
2.54%
2.47%
62K
|
Health Technology
|
8.86%
|
O:
2.64%
H:
0.0%
C:
0.0%
Acute Myocardial Infarction Treatment Market to Show Immense Growth at a CAGR of 7.7% During the Study Period (2019-2032), Predicts DelveInsight
Published:
2023-11-30
(Crawled : 22:00)
- prnewswire.com
LLY
|
News
4 d
|
$588.15
0.42%
0.09%
2M
|
Health Technology
|
-0.49%
|
O:
0.5%
H:
0.0%
C:
0.0%
treatment
show
growth
study
market
Zealand Pharma appoints Enrique Conterno and Elaine Sullivan as board observers
Published:
2023-11-30
(Crawled : 08:00)
- biospace.com/
LLY
|
News
4 d
|
$588.15
0.42%
0.09%
2M
|
Health Technology
|
-0.57%
|
O:
-0.01%
H:
0.81%
C:
-0.07%
FGEN
|
$0.553
-15.26%
-18.01%
1.2M
|
Health Technology
|
15.51%
|
O:
10.37%
H:
11.13%
C:
4.23%
pharma
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
Published:
2023-11-29
(Crawled : 04:00)
- globenewswire.com
VERV
4 d
|
$11.57
-3.66%
-3.8%
1.2M
|
Professional, Scientific, and T...
|
0.65%
|
O:
-7.79%
H:
13.21%
C:
5.66%
LLY
|
News
4 d
|
$588.15
0.42%
0.09%
2M
|
Health Technology
|
-0.62%
|
O:
-0.06%
H:
0.0%
C:
0.0%
offering
therapeutics
Metastatic Non-small Cell Lung Cancer Market Forecast Analysis and with Focus on its Immune/Molecular Biomarker Types: PD-L1, EGFR, KRAS, ALK, BRAF, MET, ROS-1, HER2, RET fusion, and NTRK1/2/3 Gene fusion | DelveInsight
Published:
2023-11-28
(Crawled : 22:00)
- prnewswire.com
JNJ
|
News
|
$158.55
-0.21%
0.01%
7.2M
|
Health Technology
|
5.13%
|
O:
-0.04%
H:
0.0%
C:
0.0%
LLY
|
News
4 d
|
$588.15
0.42%
0.09%
2M
|
Health Technology
|
-0.62%
|
O:
-0.06%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.34
-1.45%
-1.47%
1.4M
|
Health Technology
|
-0.92%
|
O:
-0.15%
H:
0.07%
C:
-0.66%
BPMC
|
$73.25
0.73%
0.72%
600K
|
Health Technology
|
7.23%
|
O:
0.5%
H:
1.86%
C:
-0.33%
lung
biomarker
cancer
cell
market
Verve Therapeutics Announces Proposed Public Offering of Common Stock and Concurrent Private Placement
Published:
2023-11-28
(Crawled : 21:00)
- globenewswire.com
VERV
4 d
|
$11.57
-3.66%
-3.8%
1.2M
|
Professional, Scientific, and T...
|
0.65%
|
O:
-7.79%
H:
13.21%
C:
5.66%
LLY
|
News
4 d
|
$588.15
0.42%
0.09%
2M
|
Health Technology
|
-0.62%
|
O:
-0.06%
H:
0.0%
C:
0.0%
offering
therapeutics
Alexandria Real Estate Equities, Inc. Announces Exclusive Partnership With Lilly to Expand Lilly Gateway Labs to San Diego
Published:
2023-11-28
(Crawled : 21:00)
- biospace.com/
LLY
|
News
4 d
|
$588.15
0.42%
0.09%
2M
|
Health Technology
|
-0.57%
|
O:
0.05%
H:
0.0%
C:
0.0%
ARE
A
|
$119.71
-0.15%
-0.59%
1.7M
|
Finance
|
13.99%
|
O:
-0.19%
H:
3.05%
C:
2.77%
partnership
PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target
Published:
2023-11-28
(Crawled : 20:00)
- prnewswire.com
LLY
|
News
4 d
|
$588.15
0.42%
0.09%
2M
|
Health Technology
|
-0.62%
|
O:
-0.06%
H:
0.0%
C:
0.0%
drug
prism
collaboration
Sermonix Pharmaceuticals Announces Five Abstracts Accepted for Presentation at 2023 San Antonio Breast Cancer Symposium
Published:
2023-11-28
(Crawled : 15:30)
- biospace.com/
LLY
|
News
4 d
|
$588.15
0.42%
0.09%
2M
|
Health Technology
|
-0.57%
|
O:
0.05%
H:
0.0%
C:
0.0%
LGND
|
$59.6
-0.45%
-0.45%
160K
|
Health Technology
|
1.02%
|
O:
0.49%
H:
0.83%
C:
-2.14%
breast
symposium
presentation
cancer
pharmaceuticals
Global Synthetic Hormones Market Analysis and Forecast, 2023-2033: Focus on Product Type, Application, Route of Administration, End User, Region, and Competitive Landscape
Published:
2023-11-25
(Crawled : 00:20)
- prnewswire.com
PFE
|
News
A
|
$29.09
-0.65%
0.03%
39M
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
4 d
|
$588.15
0.42%
0.09%
2M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$96.97
-2.04%
0.16%
2.8M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$97.95
2.98%
100
|
Health Technology
|
Email alert
Add to watchlist
global
market
Untapped Potential: Antibody Discovery Market to Surge to US$17.14 Billion by 2034 as Pharmaceutical Giants Focus on Orphan Drugs | Future Market Insights, Inc.
Published:
2023-11-22
(Crawled : 23:00)
- prnewswire.com
DHR
|
News
|
$219.44
-1.21%
0.0%
2.7M
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
4 d
|
$588.15
0.42%
0.09%
2M
|
Health Technology
|
Email alert
Add to watchlist
antibody
market
Global Beta Blockers Market Set for Robust Growth with a CAGR of 5.19% and Market Value of $11.54 Billion by 2027
Published:
2023-11-22
(Crawled : 19:00)
- prnewswire.com
SNY
|
News
|
$46.34
-1.45%
-1.47%
1.4M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$93.9
1.45%
2.1K
|
Health Technology
|
Email alert
Add to watchlist
ABT
|
News
|
$104.35
-0.8%
0.0%
4.3M
|
Health Technology
|
Email alert
Add to watchlist
XLRN
|
$179.68
0%
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
4 d
|
$588.15
0.42%
0.09%
2M
|
Health Technology
|
Email alert
Add to watchlist
global
set
growth
market
Innovent Announces Publication of Mazdutide (IBI362) Phase 2 Full Results in Chinese Patients with Type 2 Diabetes in Diabetes Care
Published:
2023-11-22
(Crawled : 05:00)
- prnewswire.com
SNYNF
|
News
|
$93.9
1.45%
2.1K
|
Health Technology
|
1.33%
|
O:
-0.74%
H:
0.71%
C:
0.71%
LLY
|
News
4 d
|
$588.15
0.42%
0.09%
2M
|
Health Technology
|
-1.65%
|
O:
-0.44%
H:
0.63%
C:
-0.05%
SNY
|
News
|
$46.34
-1.45%
-1.47%
1.4M
|
Health Technology
|
-0.09%
|
O:
-0.34%
H:
0.0%
C:
0.0%
ibi362
publication
care
chinese
diabetes
results
phase 2
Aspirin Drug Market to Soar to US$4.2 Billion by 2034, Driven by Combination Aspirin's Dominance | Future Market Insights, Inc.
Published:
2023-11-21
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$93.9
1.45%
2.1K
|
Health Technology
|
1.33%
|
O:
-0.74%
H:
0.71%
C:
0.71%
PRGO
|
$30.91
-1.44%
0.0%
1.1M
|
Health Technology
|
2.18%
|
O:
0.66%
H:
1.87%
C:
0.0%
LLY
|
News
4 d
|
$588.15
0.42%
0.09%
2M
|
Health Technology
|
-1.65%
|
O:
-0.44%
H:
0.63%
C:
-0.05%
ABT
|
News
|
$104.35
-0.8%
0.0%
4.3M
|
Health Technology
|
2.88%
|
O:
1.05%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.34
-1.45%
-1.47%
1.4M
|
Health Technology
|
-0.09%
|
O:
-0.34%
H:
0.0%
C:
0.0%
drug
market
← Previous
1
2
3
4
5
6
7
8
9
…
77
78
Next →
Gainers vs Losers
55%
45%
Top 10 Gainers
ZVSA
|
$2.03
3179.48%
96.95%
330K
|
CHSN
|
$4.89
68.63%
45.9%
5.7M
|
ANY
M
|
$1.72
60.75%
37.79%
26M
|
Technology Services
VCXA
|
News
0 d
|
$15.88
60.57%
37.72%
82K
|
CNET
|
News
|
$1.12
60.0%
37.5%
3.8M
|
Commercial Services
MFH
|
$1.62
37.29%
27.16%
6.5M
|
Technology Services
AIHS
|
$0.4389
37.16%
27.09%
230K
|
Finance
KALA
|
$8.83
36.06%
26.5%
2.7M
|
Health Technology
JNVR
|
$1.53
29.66%
21.33%
2.8M
|
WHLR
4
|
$0.3532
26.14%
20.72%
14M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.